Endoscopy: where we are now and where we might be going
- Online, ,
- 8:00 am - 5:00 pm
This will be a one-day monothematic event highlighting optimal patient pathways, top tips in optimising modifiable patient factors and current and future treatment options. The target audience for this event is consultant gastroenterologists, trainees, specialist nurses and allied health professionals.
The first session of the day will investigate the current impact of NAFLD on the NHS, with a focus on the scale of obesity and the challenge of multi-morbidity in the UK. As the day progresses delegates will hear talks on assessing liver fibrosis optimising their patients, and treatment endpoints in NAFLD. We will close the day by taking a look at emerging pharmacotherapies for NAFLD.
The programme will be made available in due course.
Registration details will be made available in due course.